Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
37
CMCM Quote, Financials, Valuation and Earnings
Last price:
$4.71
Seasonality move
:
8.81%
Day range:
$4.51 - $4.87
52-week range:
$1.99 - $6.78
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.37x
P/B ratio:
0.45x
Volume:
41.2K
Avg. volume:
58K
1-year change:
110.99%
Market cap:
$140.6M
Revenue:
$94.6M
EPS (TTM):
-$2.72
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $519.4M | $225M | $121.5M | $131.6M | $94.6M | |
| Revenue Growth (YoY) | -31.08% | -56.68% | -45.99% | 8.31% | -28.09% | |
| Cost of Revenues | $179.8M | $68.9M | $39.9M | $37.6M | $32.8M | |
| Gross Profit | $339.6M | $156.1M | $81.6M | $94M | $61.9M | |
| Gross Profit Margin | 65.38% | 69.38% | 67.16% | 71.43% | 65.36% | |
| R&D Expenses | $114M | $66M | $32.8M | $26.9M | $25.2M | |
| Selling, General & Admin | $310.7M | $166.3M | $87.1M | $102.9M | $66.7M | |
| Other Inc / (Exp) | $13M | $145.4M | -$21M | -$53M | -$69.1M | |
| Operating Expenses | $421.4M | $233.1M | $117.2M | $127.6M | $91.5M | |
| Operating Income | -$81.8M | -$77M | -$35.6M | -$33.6M | -$29.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$52.9M | $73.6M | -$52.6M | -$81.3M | -$90.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.1M | $14.1M | $2.1M | -$3.7M | -$6.2M | |
| Net Income to Company | -$54.1M | $59.6M | -$54.7M | -$77.5M | -$84M | |
| Minority Interest in Earnings | $4.3M | $807.8K | $321.8K | $1.1M | -$1.3M | |
| Net Income to Common Excl Extra Items | -$49.8M | $60.4M | -$54.4M | -$76.4M | -$85.2M | |
| Basic EPS (Cont. Ops) | -$1.82 | $2.10 | -$1.91 | -$2.69 | -$2.89 | |
| Diluted EPS (Cont. Ops) | -$1.82 | $2.07 | -$1.91 | -$2.69 | -$2.90 | |
| Weighted Average Basic Share | $27.4M | $28.1M | $28.6M | $28.9M | $29.5M | |
| Weighted Average Diluted Share | $27.4M | $28.4M | $28.6M | $28.9M | $29.5M | |
| EBITDA | -$72.4M | -$67M | -$27.7M | -$25.7M | -$24.7M | |
| EBIT | -$81.8M | -$77M | -$35.6M | -$33.6M | -$29.7M | |
| Revenue (Reported) | $519.4M | $225M | $121.5M | $131.6M | $94.6M | |
| Operating Income (Reported) | -$81.8M | -$77M | -$35.6M | -$33.6M | -$29.7M | |
| Operating Income (Adjusted) | -$81.8M | -$77M | -$35.6M | -$33.6M | -$29.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $52.7M | $30.3M | -- | $22.8M | $26.8M | |
| Revenue Growth (YoY) | -59.78% | -42.57% | -- | -24.79% | 17.8% | |
| Cost of Revenues | $16.4M | $11.5M | -- | $7M | $8.6M | |
| Gross Profit | $36.3M | $18.8M | -- | $15.8M | $18.2M | |
| Gross Profit Margin | 68.89% | 62.07% | -- | 69.45% | 67.87% | |
| R&D Expenses | $17M | $8.6M | -- | $6.3M | $9.3M | |
| Selling, General & Admin | $37.1M | $20.7M | -- | $15.3M | $19M | |
| Other Inc / (Exp) | $59.8M | $1.6M | -- | $472.3K | $3.2M | |
| Operating Expenses | $54.5M | $28.6M | -- | $21.5M | $28.3M | |
| Operating Income | -$18.2M | -$9.8M | -- | -$5.7M | -$10.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $42.6M | -$6.8M | -- | -$2.7M | -$5.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.6M | $805.3K | -- | $30.1K | $333.4K | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$625.8K | -$13.7K | -- | -$608.5K | -$706.9K | |
| Net Income to Common Excl Extra Items | $37.4M | -$7.6M | -- | -$3.4M | -$6.5M | |
| Basic EPS (Cont. Ops) | $1.30 | -$0.23 | -- | -$0.10 | -$0.23 | |
| Diluted EPS (Cont. Ops) | $1.30 | -$0.23 | -- | -$0.10 | -$0.23 | |
| Weighted Average Basic Share | $28.3M | $28.6M | -- | $29.9M | $30.2M | |
| Weighted Average Diluted Share | $28.4M | $28.6M | -- | $29.9M | $30.2M | |
| EBITDA | -$18.2M | -$9.8M | -- | -$5.7M | -$10.1M | |
| EBIT | -$18.2M | -$9.8M | -- | -$5.7M | -$10.1M | |
| Revenue (Reported) | $52.7M | $30.3M | -- | $22.8M | $26.8M | |
| Operating Income (Reported) | -$18.2M | -$9.8M | -- | -$5.7M | -$10.1M | |
| Operating Income (Adjusted) | -$18.2M | -$9.8M | -- | -$5.7M | -$10.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $270.8M | $133.6M | -- | $99.4M | $102.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $79.5M | $43.6M | -- | $34.8M | $38M | |
| Gross Profit | $191.4M | $90M | -- | $64.6M | $64.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $76.8M | $37.7M | -- | $25.3M | $30.3M | |
| Selling, General & Admin | $214.6M | $91M | -- | $70.3M | $75.1M | |
| Other Inc / (Exp) | $28.3M | $49.1M | -- | -$79.4M | -$48.7M | |
| Operating Expenses | $289.9M | $128.8M | -- | $93.8M | $105.3M | |
| Operating Income | -$98.5M | -$38.8M | -- | -$29.2M | -$40.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$62.7M | $13.3M | -- | -$100.9M | -$82.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $11.9M | -$1.5M | -- | $615.8K | -$7.2M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $7.8M | -$169.2K | -- | -$699.8K | -$1.7M | |
| Net Income to Common Excl Extra Items | -$66.8M | $14.6M | -- | -$102.2M | -$76.8M | |
| Basic EPS (Cont. Ops) | -$2.54 | $0.54 | -- | -$3.54 | -$2.72 | |
| Diluted EPS (Cont. Ops) | -$2.54 | $0.54 | -- | -$3.54 | -$2.72 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$98.5M | -$38.8M | -- | -$29.2M | -$40.6M | |
| EBIT | -$98.5M | -$38.8M | -- | -$29.2M | -$40.6M | |
| Revenue (Reported) | $270.8M | $133.6M | -- | $99.4M | $102.7M | |
| Operating Income (Reported) | -$98.5M | -$38.8M | -- | -$29.2M | -$40.6M | |
| Operating Income (Adjusted) | -$98.5M | -$38.8M | -- | -$29.2M | -$40.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $184M | $93.6M | -- | $71.5M | $79.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $53.6M | $28.5M | -- | $23.3M | $28.5M | |
| Gross Profit | $130.4M | $65.2M | -- | $48.2M | $50.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $55M | $27.2M | -- | $19.7M | $24.8M | |
| Selling, General & Admin | $141M | $66.9M | -- | $50.1M | $58.4M | |
| Other Inc / (Exp) | $126.6M | $31.5M | -- | -$26.4M | -$6.5M | |
| Operating Expenses | $195.6M | $92.7M | -- | $69.4M | $83M | |
| Operating Income | -$65.2M | -$27.6M | -- | -$21.2M | -$32.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $66.2M | $6.6M | -- | -$41.2M | -$33.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $17.1M | $2.1M | -- | $567.4K | -$527.5K | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $711.3K | -$242.5K | -- | -$1.3M | -$1.7M | |
| Net Income to Common Excl Extra Items | $49.8M | $4.3M | -- | -$43M | -$35M | |
| Basic EPS (Cont. Ops) | $1.71 | $0.16 | -- | -$1.46 | -$1.19 | |
| Diluted EPS (Cont. Ops) | $1.71 | $0.16 | -- | -$1.46 | -$1.19 | |
| Weighted Average Basic Share | $83.6M | $85.8M | -- | $87.9M | $90M | |
| Weighted Average Diluted Share | $84.1M | $85.9M | -- | $87.9M | $90M | |
| EBITDA | -$65.2M | -$27.6M | -- | -$21.2M | -$32.1M | |
| EBIT | -$65.2M | -$27.6M | -- | -$21.2M | -$32.1M | |
| Revenue (Reported) | $184M | $93.6M | -- | $71.5M | $79.5M | |
| Operating Income (Reported) | -$65.2M | -$27.6M | -- | -$21.2M | -$32.1M | |
| Operating Income (Adjusted) | -$65.2M | -$27.6M | -- | -$21.2M | -$32.1M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $140.5M | $198.9M | $248.5M | $219.7M | $285M | |
| Short Term Investments | $195.7M | $55.2M | $41.2M | $22.6M | $144.3K | |
| Accounts Receivable, Net | $67.1M | $34.5M | $26.7M | $41.1M | $56.6M | |
| Inventory | $4.5M | -- | -- | -- | -- | |
| Prepaid Expenses | $18.8M | -- | -- | -- | -- | |
| Other Current Assets | $11M | $127.9M | $75.2M | $140.3M | $137.3M | |
| Total Current Assets | $570.7M | $451.1M | $407.7M | $452.8M | $489.1M | |
| Property Plant And Equipment | $41M | $18.3M | $23.1M | $14.2M | $11.9M | |
| Long-Term Investments | $359.7M | $368.8M | $312.9M | $259.8M | $132.2M | |
| Goodwill | -- | -- | -- | -- | $81.4M | |
| Other Intangibles | $6.4M | $1.9M | $1.6M | $1.2M | $30.8M | |
| Other Long-Term Assets | $16.1M | $16.1M | $16.1M | $13.5M | $22.6M | |
| Total Assets | $1B | $859.2M | $781M | $744.9M | $794.7M | |
| Accounts Payable | $12.5M | $16.2M | $21.2M | $19.3M | $24M | |
| Accrued Expenses | $44.1M | $38.8M | $31.4M | $39.8M | $62.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $8.4M | $1.1M | $2.7M | $2.1M | $1.9M | |
| Other Current Liabilities | $13.8M | $11.6M | $8.7M | $9.3M | $9.7M | |
| Total Current Liabilities | $249.4M | $240.7M | $212.4M | $257.8M | $384.9M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $288.3M | $279.4M | $253.9M | $294.9M | $419.4M | |
| Common Stock | $32.2K | $35.8K | $36.9K | $34.2K | $34.4K | |
| Other Common Equity Adj | $48.3M | $25M | $13.8M | $51.3M | $50.3M | |
| Common Equity | $704.9M | $573.6M | $514.4M | $439.7M | $346.5M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $8.9M | $6.3M | $12.7M | $10.4M | $28.9M | |
| Total Equity | $713.8M | $579.9M | $527.2M | $450M | $375.3M | |
| Total Liabilities and Equity | $1B | $859.2M | $781M | $744.9M | $794.7M | |
| Cash and Short Terms | $336.2M | $254.2M | $289.7M | $242.3M | $285.1M | |
| Total Debt | -- | -- | -- | -- | $705.4K | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $159.6M | $244.2M | -- | -- | $218.3M | |
| Short Term Investments | $73.9M | $42M | -- | -- | $49.2K | |
| Accounts Receivable, Net | $39.3M | $30.4M | -- | -- | $59.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $160M | $81.6M | -- | -- | $192.9M | |
| Total Current Assets | $466.8M | $420.6M | -- | -- | $486.2M | |
| Property Plant And Equipment | $34.5M | $22.5M | -- | -- | $12M | |
| Long-Term Investments | $330.1M | $374.5M | -- | -- | $126.3M | |
| Goodwill | -- | -- | -- | -- | $82.3M | |
| Other Intangibles | $2.9M | $1.8M | -- | -- | $28.1M | |
| Other Long-Term Assets | $17.8M | $14.6M | -- | -- | $12.3M | |
| Total Assets | $861.4M | $842.6M | -- | -- | $774.8M | |
| Accounts Payable | $11.9M | $20.1M | -- | -- | $25.1M | |
| Accrued Expenses | $210.4M | $182.1M | -- | -- | $343.1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $246.1M | $212.4M | -- | -- | $385.7M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $299.7M | $255.7M | -- | -- | $417.4M | |
| Common Stock | $34.3K | $36.3K | -- | -- | $35.2K | |
| Other Common Equity Adj | $41.3M | $21.3M | -- | -- | $49.9M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $6.2M | $6.5M | -- | -- | $43.1M | |
| Total Equity | $561.7M | $586.9M | -- | -- | $357.4M | |
| Total Liabilities and Equity | $861.4M | $842.6M | -- | -- | $774.8M | |
| Cash and Short Terms | $233.5M | $286.2M | -- | -- | $218.3M | |
| Total Debt | $10M | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$54.1M | $59.6M | -$54.7M | -$77.5M | -$84M | |
| Depreciation & Amoritzation | $9.5M | $9.9M | $7.9M | $7.9M | $5M | |
| Stock-Based Compensation | $18.4M | $11.7M | $1.1M | $1.2M | $4.7M | |
| Change in Accounts Receivable | $18.9M | $18.8M | $19.5M | -$12.8M | -$20.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$34.7M | -$6.7M | $15.9M | -$63.2M | $77.8M | |
| Capital Expenditures | $14.8M | $8.6M | $7.3M | $1M | $1.4M | |
| Cash Acquisitions | -$37.9M | $23.2M | $7M | -- | -$33.7M | |
| Cash From Investing | -$157.1M | $272.5M | $34.2M | $28.1M | -$6.9M | |
| Dividends Paid (Ex Special Dividend) | -$72.5M | -$208M | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $10.2M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$9.5M | -- | -- | -- | |
| Repurchase of Common Stock | -$25.3K | -- | -- | -- | -- | |
| Other Financing Activities | -$187.9K | -$3.2M | -$777.5K | -- | -$128.5K | |
| Cash From Financing | -$70.2M | -$210.2M | -$1.5M | -$724.4K | -$958.2K | |
| Beginning Cash (CF) | $403.9M | $142.8M | $201.4M | $235.9M | $214.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$262M | $55.6M | $48.6M | -$35.7M | $69.9M | |
| Ending Cash (CF) | $142.7M | $188.4M | $245.4M | $225.8M | $285.6M | |
| Levered Free Cash Flow | -$49.5M | -$15.3M | $8.7M | -$64.2M | $76.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | $7.2M | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get CMCM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CMCM
Sector
P/E ratio
--
25.26x
PEG ratio
-0.03x
0.06x
P/B ratio
0.45x
2.37x
Price / LTM sales
1.37x
1.88x
Growth Metrics
CMCM
Sector
Revenue growth
17.8%
4.2%
Earnings growth
--
9.52%
Revenue (5-year growth)
-33.96%
6.47%
Earnings forecast
--
$0.12
Profitability
CMCM
Sector
Profitability FY 2023
$61.9M
$100.9M
Return on invested capital
-20.95%
1.74%
Return on assets
-9.69%
0.52%
Return on equity
-20.57%
2.9%
Earnings Date
Last Earnings Date
Dec
17
Next Earnings Date
Mar
21
Estimated Next Earnings Date
Mar
18
Balance Sheet
CMCM
Sector
Total cash
$218.3M
$58.4M
Short term investments
$144.3K
$27.5M
Total assets
$794.7M
$285.5M
Long term debt
--
$4.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
